Mineralys Therapeutics, Inc. (MLYS) has 34 open-market insider trades by 13 insiders since 2023. Over the last six months insiders net sold $3.0M. The most active filer is David Malcom Rodman.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Srinivas Akkaraju | Dir | — | 3 | $53.1M | 2026-02-19 |
| Catalys Pacific Fund, LP | Dir10% Owner | — | 1 | $43.4M | 2025-11-20 |
| RA Capital Management, L.P. | Dir | — | 2 | $38.8M | 2026-03-30 |
| RA Capital Nexus Fund III, L.P. | Dir | — | 2 | $37.5M | 2025-03-13 |
| Brian Taylor Slingsby | Dir | — | 4 | $21.2M | 2026-09-22 |
| Jon Congleton | CEO | — | 6 | $18.6M | 2026-07-13 |
| David Malcom Rodman | — | — | 8 | $15.9M | 2026-08-10 |
| Samsara BioCapital, L.P. | 10% Owner | — | 1 | $15.0M | 2024-02-12 |
| Adam Scott Levy | CFOSecretary | — | 4 | $10.5M | 2026-02-19 |
| Rajeev M. Shah | Dir | — | 1 | $8.8M | 2026-03-30 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Jon Congleton | CEO | Sell | $1.9M | 2026-09-30 |
| Brian Taylor Slingsby | Director | Sell | $3.0M | 2026-09-22 |
| Eric Warren | CCO | Sell | $209K | 2026-09-21 |
| Daphne Karydas | Director | Sell | $86K | 2026-09-15 |
| Eric Warren | CCO | Sell | $193K | 2026-08-21 |
| David Malcom Rodman | — | Sell | $59K | 2026-08-10 |
Companies that share insiders with MLYS, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Eric Warren | CCO | Sell | $200K | 2026-07-21 |
| David Malcom Rodman | — | Sell | $11K | 2026-07-17 |
| Jon Congleton | CEO | Sell | $291K | 2026-07-13 |
| David Malcom Rodman | — | Sell | $557K | 2026-07-13 |
| David Malcom Rodman | — | Sell | $66K | 2026-07-09 |
| Jon Congleton | CEO | Sell | $2.0M | 2026-06-30 |
| Eric Warren | CCO | Sell | $2.7M | 2026-06-26 |
| Daphne Karydas | Director | Sell | $75K | 2026-06-17 |
| David Malcom Rodman | — | Sell | $350K | 2026-06-15 |